FDA Inspection 1168200 — The Mount Sinai Hospital
The FDA completed an inspection of The Mount Sinai Hospital on April 13, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 13, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)